U.S. Oil and Gas Stock News

Latest AUM update and earnings context Cohen & Steers (CNS) reported preliminary assets under management of US$93.1b as of January 31, 2026, tied to market appreciation and net inflows, alongside ongoing revenue growth and maintained profitability, despite earnings that were slightly below forecast. See our latest analysis for Cohen & Steers. At a share price of US$64.30, Cohen & Steers has seen a 2.54% 1 day share price return and a modest 0.97% 7 day share price return. Its 1 year total...

If you are wondering whether U-Haul Holding is starting to look appealing at its current share price, this article walks through what that price might really imply about value. The stock recently closed at US$48.81, with returns of 14.7% decline over 7 days, 10.9% decline over 30 days, 3.4% decline year to date, and 31.3% decline over 1 year, which may have changed how some investors view its risk and potential. Recent coverage around U-Haul often focuses on its core role in truck and...

Affirm Holdings (NasdaqGS:AFRM) recently announced new partnerships and expansions with Intuit's QuickBooks Payments, Expedia Group, Bolt, and Wayfair. These agreements are intended to widen Affirm's reach across financial software, travel bookings, ecommerce checkout, and home goods retail, including international markets. The collaborations focus on integrating Affirm's buy now, pay later services into partner platforms to reach additional merchants and consumers. Affirm operates in the...

EVA Live (Nasdaq:GOAI) has now clarified how it intends to approach capital allocation in its next phase of growth.

Donaldson Company (DCI) is back in focus after the board said chief operating officer Richard Lewis will take over as president and chief executive officer, while long-time leader Tod Carpenter becomes executive chairman. See our latest analysis for Donaldson Company. The leadership change headlines come as the share price sits at $109.20, with a 30 day share price return of 15.02% and year to date gain of 21.43%, while the 1 year total shareholder return of 56.84% points to strong momentum...

Avnet (AVT) is back in focus after reporting second quarter results that combined higher year over year sales with lower net income and earnings per share, and issuing fresh GAAP EPS guidance for the coming quarter. See our latest analysis for Avnet. The latest earnings update, together with recently completed buybacks, comes as Avnet’s share price sits at US$66.35, with a 30 day share price return of 33.10% and a 90 day share price return of 40.63%. The 1 year total shareholder return of...

Why Natural Resource Partners Is On Investors’ Radar Natural Resource Partners (NRP) has drawn attention after recent gains, with the unit price closing at US$123.04 and positive total returns over the past month, past 3 months, and year. For investors following income oriented partnerships and mineral rights businesses, those returns, combined with reported revenue of US$218.701 million and net income of US$145.179 million, raise questions about how the market is currently valuing NRP’s...

In the past few days, Huron Consulting Group highlighted its ongoing share repurchase activity and continued expansion of its service offerings through acquisitions, reinforcing its current business trajectory. Investors appear to be focusing on how this combination of capital returns and broader capabilities could underpin the company’s longer-term consulting outlook and appeal. Next, we’ll examine how Huron’s active share buybacks shape its investment narrative and what that could mean...

Mirum Pharmaceuticals recently announced that Health Canada has authorized LIVMARLI (maralixibat) oral solution and tablet for treating cholestatic pruritus in PFIC patients aged 12 months and older, expanding its availability alongside its existing authorization for Alagille syndrome in Canada. This authorization is underpinned by the Phase 3 MARCH study, the largest randomized PFIC trial to date, which showed highly statistically significant pruritus reduction across multiple genetic PFIC...

Edgewell Personal Care (EPC) has opened fiscal 2026 with Q1 results that sit against a mixed recent track record, where quarterly revenue has ranged from US$478.4 million to US$647.8 million and basic EPS has swung between a loss of US$0.66 and a profit of US$0.99 over the past six reported quarters. Over that same stretch, trailing twelve month revenue hovered around US$2.2 billion while EPS moved from US$1.98 to US$0.53, highlighting how earnings have been far more volatile than sales. With...

ON Semiconductor (NasdaqGS:ON) approved a new share repurchase program of up to US$6b. The company completed its prior capital return program before authorizing the new buyback. Management highlighted progress in AI data center related revenues and operational improvements aligned with long term margin goals. ON Semiconductor focuses on power and analog semiconductors used in areas such as industrial applications, automotive systems and computing. The new US$6b buyback and the update on AI...

GE HealthCare Technologies (NasdaqGS:GEHC) has introduced ReadyFix, a remote fleet management solution for healthcare systems. The company has also received FDA 510(k) clearance and CE Marking for Allia Moveo, an imaging system for interventional suites. Both product milestones expand the company’s presence in digital health and interventional imaging. For you as an investor, these launches sit in the core of GE HealthCare’s business in medical imaging, digital tools and service support for...

If you are wondering whether NCR Voyix is priced attractively or not, this article will walk through what the current share price might be implying about value. The stock last closed at US$9.81, after a 7.0% gain over the past week, although returns over 30 days, year to date and the last year sit at 11.1%, 0.5% and 22.0% declines respectively. Recent attention on NCR Voyix has focused on how the business is reshaping itself around software and services for payments and retail technology,...

If you are wondering whether Aramark at around US$38.80 is offering fair value or hiding a margin of safety, you are asking the right question before making any long term decisions. The share price sits near US$38.80, with returns of 1.9% over 7 days, 6.1% year to date and 4.5% over 1 year. The 3 year and 5 year returns of 42.6% and 53.8% hint at a stock that has already moved a fair distance. Recent news around Aramark has largely focused on its role as a major provider of food, facilities...

What the latest earnings tell you about Freedom Holding Freedom Holding (FRHC) just released results for the third quarter and nine months to December 31, 2025, with both revenue and net income lower than the same periods a year earlier. For the quarter, revenue came in at US$628.62 million versus US$664.58 million a year ago, while net income was US$76.24 million compared with US$78.28 million. Basic earnings per share from continuing operations were US$1.27, with diluted EPS at US$1.25,...

Kirby (KEX) is back in focus after reporting fourth quarter revenue of US$851.78 million and net income of US$91.81 million, alongside an update on its long running share repurchase program. See our latest analysis for Kirby. The latest earnings and ongoing buybacks come after a strong 90 day share price return of 8.98% and a 1 year total shareholder return of 11.90%, with 3 and 5 year total shareholder returns of 64.86% and 97.51%. This suggests longer term momentum has been stronger than...

Lennox International (NYSE:LII) has completed a new share repurchase tranche, buying back nearly 0.85% of its shares in the most recent quarter. This brings total buybacks under the long running program to almost 40% of the company’s outstanding shares. The latest activity reflects an ongoing focus on returning capital to shareholders through repurchases. For investors watching NYSE:LII, the scale of the buyback program is now a core part of the story. The stock closed at $529.29, with...

In the past year, Liberty Broadband reported a net loss of US$2,676 million for 2025, compared with net income of US$869 million in 2024, while also completing a long-running share repurchase totaling 58,804,650 shares for US$8,115.32 million under its 2016 authorization. This sharp swing from profit to loss, alongside the conclusion of a very large multi-year buyback, raises important questions about how Liberty Broadband balances capital returns with earnings quality. With recent share...

Mettler-Toledo International (NYSE:MTD) reported strong Q4 results, with broad-based growth across regions and product lines. The company reached US$1b in annual service revenue for the first time, marking a key milestone in its service business. Management highlighted continued progress in automation and digitalization initiatives, alongside expansion in emerging markets and high-growth segments. Results came despite ongoing headwinds from tariffs and currency movements. Mettler-Toledo...

Biogen (NasdaqGS:BIIB) reports strong commercial performance for Alzheimer’s treatment Leqembi, reflected in collaboration revenues and in market sales. The US FDA grants Breakthrough Therapy Designation to litifilimab for cutaneous lupus erythematosus, marking a key step in Biogen’s immunology efforts. Biogen announces promising clinical results for a high dose SPINRAZA regimen for spinal muscular atrophy, with regulatory review ongoing in the US and approvals already in the EU and...

MGM Resorts International recently reported fourth-quarter 2025 results showing higher sales of US$3,433.3 million and revenue of US$4,605.27 million, alongside completing two share repurchase programs totaling US$2,389.19 million and recording a US$22.79 million goodwill impairment. Management highlighted record profitability in Macau, a sharp improvement at BetMGM, and the easing of renovation-related disruption in Las Vegas as key operational themes. With these updates and management’s...

If you are looking at Kinetik Holdings and wondering whether the recent price is fair, rich, or leaves some room on the table, you are in the right place for a clear look at value. The stock closed at US$42.25, with returns of 5.3% over the last 7 days, 15.1% over the last 30 days, 15.9% year to date, and a 28.4% decline over the past year, while the 3 year return sits at 80.7%. These moves are sitting against a backdrop of ongoing interest in US energy infrastructure and midstream names,...

If you are wondering whether Omega Healthcare Investors is still fairly priced after its recent run, you are not alone. This article focuses squarely on what you are getting for the current share price. With the stock at US$44.79 and returns of 4.1% over 7 days, 1.2% over 30 days, 0.6% year to date, 29.8% over 1 year, 97.0% over 3 years and 78.7% over 5 years, many investors are now asking whether the current price reflects its fundamentals or already incorporates higher expectations and...

In January 2026, SL Green Realty Corp. reported full-year 2025 results showing sales of US$601.54 million and revenue of US$1.00 billion, but a net loss of US$230.93 million and basic loss per share from continuing operations of US$1.61, reversing a profit a year earlier. The company also shifted its dividend policy, moving from monthly to quarterly cash payments beginning in fiscal 2026, a change that can influence how income-focused investors view the reliability and timing of its...